1 Report Prologue
1.1 Introduction 19
1.2 Scope Of Study 19
1.3 Research Objective 19
1.4 Assumptions & Limitations 20
1.4.1 Assumptions 20
1.4.2 Limitations 20
2 Research Methodology
2.1.1 Primary Research Methodology 23
2.1.2 Secondary Research Methodology 24
2.1.3 Market Share Analysis 24
2.1.4 Market Pricing Approach 24
3 Market Dynamics
3.1 Introduction 26
3.2 Drivers 27
3.2.1 Increasing Prevalence Of Neurovascular Diseases Like Brain Aneurysm, Arteriovenous Malformations (AVMs), And Others, Will Propel The Neurovascular Devices Market 27
3.2.2 Favourable Reimbursement Policies Provide Favorable Background For Market Growth 28
3.2.3 Rising Demands For Minimally Invasive Therapeutic Procedures And Growing Geriatric Population Will Drive The Neurovascular Devices Market Growth 29
3.2.4 Ongoing Product Development & Commercialization Will Boost The Neurovascular Devices Market 30
3.3 Restraints 31
3.3.1 High Procedural Cost By Neurovascular Devices 31
3.3.2 Cases Of Injury And Need For Physician Training 32
3.4 Opportunity 33
3.5 Mega Trend 33
3.5.1.1 Increasing Use Of Endovascular Embolization For The Treatment Of Brain Aneurysm 33
3.6 Macroeconomic Indicators 33
4 Market Factor Analysis
4.1 Value Chain Analysis 35
4.1.1 R&D And Designing 35
4.1.2 Manufacturing 36
4.1.3 Distribution & Sales 36
4.1.4 Post-Sales Review 36
4.2 Porterโs Five Forces Model 37
4.2.1 Bargaining Power Of Suppliers 38
4.2.2 Bargaining Power Of Buyers 38
4.2.3 Threat Of New Entrants 38
4.2.4 Threat Of Substitutes 38
4.2.5 Intensity Of Rivalry 38
4.3 Investment Opportunities 38
4.4 Pricing Analysis 39
4.5 Demand & Supply: Gap Analysis 39
5 Neurovascular Devices Market, By Product
5.1 Introduction 41
5.1.1 Aneurysm Coiling & Embolization Devices 43
5.1.1.1 Embolic Coils 43
5.1.1.1.1 Detachable Coils 44
5.1.1.1.2 Pushable Coils 44
5.1.1.2 Flow Diversion Devices 45
5.1.1.3 Liquid Embolic 45
5.1.2 Neurothrombectomy Devices 45
5.1.2.1 Retrieval Systems 46
5.1.2.2 Suction And Aspiration Devices 46
5.1.3 Support Device 47
5.1.3.1 Microcatheters 47
5.1.3.2 Microguidewires 48
5.1.4 Cerebral Balloon Angioplasty And Stenting Systems 48
5.1.4.1 Carotid Artery Stents 49
5.1.4.2 Embolic Protection Systems 49
5.1.4.2.1 Balloon Occlusion Devices 50
5.1.4.2.2 Distal Filter Devices 50
6 Neurovascular Devices Market, By Therapeutic Application
6.1 Introduction 52
6.1.1 Hemorrhagic Stroke 53
6.1.2 Ischemic Strokes 53
7 Neurovascular Devices Market, By End User
7.1 Introduction 55
7.1.1 Hospitals & Clinics 56
7.1.2 Ambulatory Surgical Units 56
8 Global Neurovascular Devices Market, By Region
8.1 Introduction 58
8.2 Americas 59
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.2.1 North America 63
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.2.1.1 U.S. 67
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.2.1.2 Canada 71
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.2.2 South America 74
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3 Europe 77
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1 Western Europe 82
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.1 Germany 86
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.2 France 89
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.3 U.K 92
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.4 Italy 95
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.5 Spain 98
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.1.6 Rest Of Western Europe 101
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.3.2 Eastern Europe 104
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4 Asia Pacific 108
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.1 Japan 113
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.2 China 116
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.3 India 119
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.4 Australia 122
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.5 Republic Of Korea 125
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.4.6 Rest Of Asia Pacific 128
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5 Middle East & Africa 131
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.1 United Arab Emirates 136
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.2 Saudi Arabia 139
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.3 Oman 142
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.4 Kuwait 145
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.5 Qatar 148
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
8.5.6 Rest Of Middle East & Africa 151
Neurovascular Devices Market, By Product
Neurovascular Devices Market, By Therapeutic Application
Neurovascular Devices Market, By End User
9 Company Landscape
9.1 Company Share Analysis 155
10 Company Profiles
10.1 Stryker 157
10.1.1 Company Overview 157
10.1.2 Financials 157
10.1.3 Products 157
10.1.4 Strategy 157
10.1.5 Key Developments 157
10.2 Medtronic 158
10.2.1 Company Overview 158
10.2.2 Financials 158
10.2.3 Products 158
10.2.4 Strategy 158
10.2.5 Key Developments 158
10.3 Johnson & Johnson Services, Inc 159
10.3.1 Company Overview 159
10.3.2 Financials 159
10.3.3 Products 159
10.3.4 Strategy 159
10.3.5 Key Developments 159
10.4 TERUMO CORPORATION 160
10.4.1 Company Overview 160
10.4.2 Financials 160
10.4.3 Products 160
10.4.4 Strategy 160
10.4.5 Key Developments 160
10.5 Abbott 161
10.5.1 Company Overview 161
10.5.2 Financials 161
10.5.3 Products 161
10.5.4 Strategy 161
10.5.5 Key Developments 161
10.6 Merit Medical Systems, Inc. 162
10.6.1 Company Overview 162
10.6.2 Financials 162
10.6.3 Products 162
10.6.4 Strategy 162
10.6.5 Key Developments 162
10.7 Medikit Co., Ltd. 163
10.7.1 Company Overview 163
10.7.2 Financials 163
10.7.3 Products 163
10.7.4 Strategy 163
10.7.5 Key Developments 163
10.8 Penumbra, Inc. 164
10.8.1 Company Overview 164
10.8.2 Financials 164
10.8.3 Products 164
10.8.4 Strategy 164
10.8.5 Key Developments 164
10.9 MicroPort Scientific Corporatio 165
10.9.1 Company Overview 165
10.9.2 Financials 165
10.9.3 Products 165
10.9.4 Strategy 165
10.9.5 Key Developments 165
10.10 Evasc 166
10.10.1 Company Overview 166
10.10.2 Financials 166
10.10.3 Products 166
10.10.4 Strategy 166
10.10.5 Key Developments 166
10.11 Rapid Medical 167
10.11.1 Company Overview 167
10.11.2 Financials 167
10.11.3 Products 167
10.11.4 Strategy 167
10.11.5 Key Developments 167
11 Conclusion
11.1 Key Findings 169
11.1.1 CEOโs Viewpoint 169
11.1.2 Key Companies To Watch 169
11.1.3 Prediction Of NEUROVASCULAR Devices Industry 169
12 Appendix
12.1 Discussion Blue Print 171
12.2 References 173
13 List Of Tables
TABLE 1 PRIMARY INTERVIEWS 23
TABLE 2 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 42
TABLE 3 GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 43
TABLE 4 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 43
TABLE 5 GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 43
TABLE 6 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC COILS, BY REGION 2020-2027 (USD MILLION) 44
TABLE 7 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DETACHABLE COILS, BY REGION 2020-2027 (USD MILLION) 44
TABLE 8 GLOBAL NEUROVASCULAR DEVICES MARKET FOR PUSHABLE COILS, BY REGION 2020-2027 (USD MILLION) 44
TABLE 9 GLOBAL NEUROVASCULAR DEVICES MARKET FOR FLOW DIVERSION DEVICES, BY REGION 2020-2027 (USD MILLION) 45
TABLE 10 GLOBAL NEUROVASCULAR DEVICES MARKET FOR LIQUID EMBOLIC, BY REGION 2020-2027 (USD MILLION) 45
TABLE 11 GLOBAL NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 45
TABLE 12 GLOBAL NEUROVASCULAR DEVICES MARKET FOR NEUROTHROMBECTOMY DEVICES, BY REGION 2020-2027 (USD MILLION) 46
TABLE 13 GLOBAL NEUROVASCULAR DEVICES MARKET FOR RETRIEVAL SYSTEMS , BY REGION 2020-2027 (USD MILLION) 46
TABLE 14 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUCTION AND ASPIRATION DEVICES, BY REGION 2020-2027 (USD MILLION) 46
TABLE 15 GLOBAL NEUROVASCULAR DEVICES MARKET, SUPPORT DEVICES 2020-2027 (USD MILLION) 47
TABLE 16 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUPPORT DEVICES, BY REGION 2020-2027 (USD MILLION) 47
TABLE 17 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROCATHETERS, BY REGION 2020-2027 (USD MILLION) 47
TABLE 18 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROGUIDEWIRES, BY REGION 2020-2027 (USD MILLION) 48
TABLE 19 GLOBAL NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 48
TABLE 20 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS, BY REGION 2020-2027 (USD MILLION) 48
TABLE 21 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENTS, BY REGION 2020-2027 (USD MILLION) 49
TABLE 22 GLOBAL NEUROVASCULAR DEVICES MARKET, EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 49
TABLE 23 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC PROTECTION SYSTEMS, BY REGION 2020-2027 (USD MILLION) 49
TABLE 24 GLOBAL NEUROVASCULAR DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION 2020-2027 (USD MILLION) 50
TABLE 25 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DISTAL FILTER DEVICES, BY REGION 2020-2027 (USD MILLION) 50
TABLE 26 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 52
TABLE 27 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HEMORRHAGIC STROKE, BY REGION 2020-2027 (USD MILLION) 53
TABLE 28 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES MARKET, BY REGION 2020-2027 (USD MILLION) 53
TABLE 29 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 55
TABLE 30 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HOSPITALS & CLINICS MARKET, BY REGION 2020-2027 (USD MILLION) 56
TABLE 31 GLOBAL NEUROVASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL UNITS MARKET, BY REGION 2020-2027 (USD MILLION) 56
TABLE 32 GLOBAL NEUROVASCULAR DEVICESCS MARKET, BY REGION 2020-2027 (USD MILLION) 58
TABLE 33 AMERICAS NEUROVASCULAR DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 60
TABLE 34 AMERICAS NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 60
TABLE 35 AMERICAS NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 61
TABLE 36 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 61
TABLE 37 AMERICAS NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 61
TABLE 38 AMERICAS NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 62
TABLE 39 AMERICAS NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 62
TABLE 40 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 62
TABLE 41 AMERICAS NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 63
TABLE 42 AMERICAS NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 63
TABLE 43 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 63
TABLE 44 NORTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 64
TABLE 45 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 64
TABLE 46 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 65
TABLE 47 NORTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 65
TABLE 48 NORTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 65
TABLE 49 NORTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 66
TABLE 50 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 66
TABLE 51 NORTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 66
TABLE 52 NORTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 67
TABLE 53 U.S.NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 67
TABLE 54 U.S.NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 68
TABLE 55 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 68
TABLE 56 U.S.NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 68
TABLE 57 U.S.NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 69
TABLE 58 U.S.NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 69
TABLE 59 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 70
TABLE 60 U.S.NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 70
TABLE 61 U.S.NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 70
TABLE 62 CANADA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 71
TABLE 63 CANADA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 71
TABLE 64 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 71
TABLE 65 CANADA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 72
TABLE 66 CANADA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 72
TABLE 67 CANADA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 72
TABLE 68 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 73
TABLE 69 CANADA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 73
TABLE 70 CANADA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 73
TABLE 71 SOUTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2020-2027 (USD MILLION) 74
TABLE 72 SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 74
TABLE 73 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2020-2027 (USD MILLION) 74
TABLE 74 SOUTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 75
TABLE 75 SOUTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 75
TABLE 76 SOUTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 75
TABLE 77 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 76
TABLE 78 SOUTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 76
TABLE 79 SOUTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2020-2027 (USD MILLION) 76
TABLE 80 EUROPE NEUROVASCULAR DEVICES MARKET, BY REGION 2020-2027 (USD MILLION) 78
TABLE 81 EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 79
TABLE 82 EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 79
TABLE 83 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 79
TABLE 84 EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 80
TABLE 85 EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 80
TABLE 86 EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 80
TABLE 87 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 81
TABLE 88 EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 81
TABLE 89 EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 81
TABLE 90 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 82
TABLE 91 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 82
TABLE 92 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2020-2027 (USD MILLION) 82
TABLE 93 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 84
TABLE 94 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 84
TABLE 95 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 84
TABLE 96 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 85
TABLE 97 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 85
TABLE 98 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 85
TABLE 99 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 86
TABLE 100 GERMANY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 86
TABLE 101 GERMANY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 87
TABLE 102 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 87
TABLE 103 GERMANY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 87
TABLE 104 GERMANY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 88
TABLE 105 GERMANY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 88
TABLE 106 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 88
TABLE 107 GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 89
TABLE 108 GERMANY NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 89
TABLE 109 FRANCE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 89
TABLE 110 FRANCE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 90
TABLE 111 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 90
TABLE 112 FRANCE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 90
TABLE 113 FRANCE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 91
TABLE 114 FRANCE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 91
TABLE 115 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 91
TABLE 116 FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 92
TABLE 117 FRANCE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 92
TABLE 118 U.K NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 92
TABLE 119 U.K NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 93
TABLE 120 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 93
TABLE 121 U.K NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 93
TABLE 122 U.K NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 94
TABLE 123 U.K NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 94
TABLE 124 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 94
TABLE 125 U.K NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 95
TABLE 126 U.K NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 95
TABLE 127 ITALY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 95
TABLE 128 ITALY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 96
TABLE 129 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 96
TABLE 130 ITALY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 96
TABLE 131 ITALY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 97
TABLE 132 ITALY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 97
TABLE 133 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 97
TABLE 134 ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 98
TABLE 135 ITALY NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 98
TABLE 136 SPAIN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 98
TABLE 137 SPAIN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 99
TABLE 138 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 99
TABLE 139 SPAIN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 99
TABLE 140 SPAIN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 100
TABLE 141 SPAIN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 100
TABLE 142 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 100
TABLE 143 SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 101
TABLE 144 SPAIN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 101
TABLE 145 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 101
TABLE 146 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 102
TABLE 147 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 102
TABLE 148 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 102
TABLE 149 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 103
TABLE 150 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 103
TABLE 151 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 103
TABLE 152 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 104
TABLE 153 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 104
TABLE 154 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 104
TABLE 155 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 105
TABLE 156 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 105
TABLE 157 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 105
TABLE 158 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 106
TABLE 159 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 106
TABLE 160 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 106
TABLE 161 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 107
TABLE 162 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 107
TABLE 163 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 107
TABLE 164 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 107
TABLE 165 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 109
TABLE 166 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 110
TABLE 167 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 110
TABLE 168 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 110
TABLE 169 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 111
TABLE 170 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 111
TABLE 171 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 111
TABLE 172 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 112
TABLE 173 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 112
TABLE 174 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 112
TABLE 175 JAPAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 113
TABLE 176 JAPAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 113
TABLE 177 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 113
TABLE 178 JAPAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 114
TABLE 179 JAPAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 114
TABLE 180 JAPAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 114
TABLE 181 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 115
TABLE 182 JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 115
TABLE 183 JAPAN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 115
TABLE 184 CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 116
TABLE 185 CHINA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 116
TABLE 186 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 116
TABLE 187 CHINA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 117
TABLE 188 CHINA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 117
TABLE 189 CHINA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 117
TABLE 190 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 118
TABLE 191 CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 118
TABLE 192 CHINA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 118
TABLE 193 INDIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 119
TABLE 194 INDIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 119
TABLE 195 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 119
TABLE 196 INDIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 120
TABLE 197 INDIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 120
TABLE 198 INDIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 120
TABLE 199 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 121
TABLE 200 INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 121
TABLE 201 INDIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 121
TABLE 202 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 122
TABLE 203 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 122
TABLE 204 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 122
TABLE 205 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 123
TABLE 206 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 123
TABLE 207 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 123
TABLE 208 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 124
TABLE 209 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 124
TABLE 210 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 124
TABLE 211 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 125
TABLE 212 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 125
TABLE 213 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 125
TABLE 214 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 126
TABLE 215 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 126
TABLE 216 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 126
TABLE 217 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 127
TABLE 218 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 127
TABLE 219 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 127
TABLE 220 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 128
TABLE 221 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 128
TABLE 222 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 128
TABLE 223 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 129
TABLE 224 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 129
TABLE 225 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 129
TABLE 226 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 130
TABLE 227 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 130
TABLE 228 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 130
TABLE 229 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2020-2027 (USD MILLION) 132
TABLE 230 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 133
TABLE 231 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 133
TABLE 232 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 133
TABLE 233 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 134
TABLE 234 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 134
TABLE 235 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 134
TABLE 236 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 135
TABLE 237 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLUICATION 2020-2027 (USD MILLION) 135
TABLE 238 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USERM 2020-2027 (USD MILLION) 135
TABLE 239 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 136
TABLE 240 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 136
TABLE 241 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 136
TABLE 242 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 137
TABLE 243 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 137
TABLE 244 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 137
TABLE 245 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 138
TABLE 246 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 138
TABLE 247 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 138
TABLE 248 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 139
TABLE 249 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 139
TABLE 250 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 139
TABLE 251 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 140
TABLE 252 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 140
TABLE 253 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 140
TABLE 254 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 141
TABLE 255 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 141
TABLE 256 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 141
TABLE 257 OMAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 142
TABLE 258 OMAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 142
TABLE 259 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 142
TABLE 260 OMAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 143
TABLE 261 OMAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 143
TABLE 262 OMAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 143
TABLE 263 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 144
TABLE 264 OMAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 144
TABLE 265 OMAN NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 144
TABLE 266 KUWAIT NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 145
TABLE 267 KUWAIT NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 145
TABLE 268 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 145
TABLE 269 KUWAIT NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 146
TABLE 270 KUWAIT NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 146
TABLE 271 KUWAIT NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 146
TABLE 272 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 147
TABLE 273 KUWAIT NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 147
TABLE 274 KUWAIT NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 147
TABLE 275 QATAR NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 148
TABLE 276 QATAR NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 148
TABLE 277 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 148
TABLE 278 QATAR NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 149
TABLE 279 QATAR NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 149
TABLE 280 QATAR NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 149
TABLE 281 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 150
TABLE 282 QATAR NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 150
TABLE 283 QATAR NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION) 150
TABLE 284 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020-2027 (USD MILLION) 151
TABLE 285 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2020-2027 (USD MILLION) 151
TABLE 286 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2020-2027 (USD MILLION) 151
TABLE 287 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2020-2027 (USD MILLION) 152
TABLE 288 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2020-2027 (USD MILLION) 152
TABLE 289 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2020-2027 (USD MILLION) 152
TABLE 290 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2020-2027 (USD MILLION) 153
TABLE 291 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020-2027 (USD MILLION) 153
TABLE 292 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USER 2020-2027 (USD MILLION)
153
14 List Of Figures
FIGURE 1 GLOBAL NEUROVASCULAR DEVICES: MARKET STRUCTURE 20
FIGURE 2 RESEARCH METHODOLOGY 22
FIGURE 3 GLOBAL NEUROVASCULAR DEVICES MARKET: FORECAST MODEL 24
FIGURE 4 VALUE CHAIN: NEUROVASCULAR DEVICES MARKET 35
FIGURE 5 PORTERS FIVE FORCES MODEL: GLOBAL NEUROVASCULAR DEVICES MARKET 37
FIGURE 6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 42
FIGURE 7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2020 & 2027 (USD MILLION) 52
FIGURE 8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2020 & 2027 (USD MILLION) 55
FIGURE 9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION 2020 & 2027 (USD MILLION) 58
FIGURE 10 AMERICAS NEUROVASCULAR DEVICES MARKET SHARE, BY REGION 2020 (%) 60
FIGURE 11 EUROPE NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 78
FIGURE 12 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 109
FIGURE 13 MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 132
FIGURE 14 GLOBAL NEUROVASCULAR DEVICES MARKET COMPANY SHARE ANALYSIS, 2020 (%) 155